EUVIMEDObjevte EUVIMED
Crossref

Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation

Weiliang Zhang, Qi Ji, Qingwei Wang, Lixia Liu, Xin Liu, Conglian Qiu, Hui Zhang, Zhizhuo Du, Li Gao, Peifang Xiao, Jing Ling, Liyan Fan and 9 more

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70474 ↗

At a glance

Journal article in Clinical Transplantation, 2026. Written by Weiliang Zhang and 20 co-authors. Institution: Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China. Major MEDLINE topics: Cystitis, Hemorrhagic, Hematopoietic Stem Cell Transplantation, Polymorphism, Single Nucleotide, Cytochrome P-450 CYP2C19. 45 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Children's Hospital of Soochow University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) can potentially cure various hematologic disorders. However, transplant‐related complications, including hemorrhagic cystitis (HC), remain major causes of adverse outcomes and decreased survival. This study examines the associations of HC with pharmacogenetic single nucleotide polymorphisms (SNPs) and clinical characteristics.

Methods

This retrospective study included 259 pediatric patients who underwent allo‐HSCT. HC was predefined as the primary endpoint, and other major complications were analyzed as secondary exploratory outcomes. Bone marrow samples were collected at initial diagnosis for genomic DNA extraction. SNP genotyping was performed by targeted next‐generation sequencing via a customized 30‐gene panel.

Results

Among the 30 SNPs analyzed, all except CYP2C19 (c.99T > C) were in Hardy‐Weinberg equilibrium (all p > 0.05). In univariate Cox regression, CYP2C19 (c.681G > A) GA/AA genotype, older age, higher body weight, haploidentical transplantation, use of cord blood in the graft, peri‐engraftment syndrome (peri‐ES), severe acute graft‐versus‐host disease, and cytomegalovirus infection were significantly associated with an increased risk of HC, whereas HLA 9/10‐10/10 match appeared protective (all p < 0.05). Multivariate Cox analysis identified CYP2C19 (c.681G > A) GA/AA (hazard ratio (HR) = 1.90, p = 0.021), older age ( HR = 2.14, p = 0.036), and peri‐ES ( HR = 1.86, p = 0.034) as independent risk factors for HC.

Conclusion

This study demonstrates that CYP2C19 (c.681G > A) GA/AA genotype, older age, and peri‐ES are each independent risk factors for HC after allo‐HSCT. These findings highlight the value of pharmacogenetic and clinical profiling in predicting susceptibility to HC and guiding personalized preventive strategies, contributing to a deeper understanding of the interplay among genetic predisposition, immune responses, and chemotherapy‐related toxicity in HC pathogenesis.

Subjects

MeSH terms (MEDLINE)

Cystitis, HemorrhagicHematopoietic Stem Cell TransplantationPolymorphism, Single NucleotideCytochrome P-450 CYP2C19Graft vs Host DiseaseHumansFemaleMaleChildRetrospective StudiesChild, PreschoolFollow-Up StudiesPrognosisTransplantation, HomologousInfantAdolescentRisk FactorsGenotype

Author keywords

CYP2C19HCHSCTSNPperi‐ES

Substances

Cytochrome P-450 CYP2C19CYP2C19 protein, human

Authors and institutions

  • Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
  • Department of Medical Affairs, Acornmed Biotechnology Co., Ltd, Beijing, China.
  • Department of Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, China.

ORCID profiles: Bohan Li, Jiayue Qin

Funding

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Children's Hospital of Soochow University

Cite

APA

Zhang, W., Ji, Q., Wang, Q., Liu, L., Liu, X., Qiu, C., Zhang, H., Du, Z., Gao, L., Xiao, P., Ling, J., Fan, L., Bian, X., Li, J., Hu, Y., Li, B., Zhang, Y., Lu, J., Wu, S., …, & Hu, S. (2026). Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70474

Vancouver

Zhang W, Ji Q, Wang Q, Liu L, Liu X, Qiu C, et al. Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. 2026. doi:10.1111/ctr.70474

BibTeX
@article{Zhang2026,
  author = {Zhang, Weiliang and Ji, Qi and Wang, Qingwei and Liu, Lixia and Liu, Xin and Qiu, Conglian and Zhang, Hui and Du, Zhizhuo and Gao, Li and Xiao, Peifang and Ling, Jing and Fan, Liyan and Bian, Xinni and Li, Jie and Hu, Yixin and Li, Bohan and Zhang, Yongping and Lu, Jun and Wu, Shuiyan and Qin, Jiayue and Hu, Shaoyan},
  title = {Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70474}
}
Start for free →